No Data
U.S. Pharma Imports Soar in March as Drugmakers Look to Get Ahead of Potential Tariffs
Investors Three-year Losses Continue as Pfizer (NYSE:PFE) Dips a Further 7.9% This Week, Earnings Continue to Decline
Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond?
Pfizer Options Spot-On: On May 9th, 111.82K Contracts Were Traded, With 3.55 Million Open Interest
Catalyst Watch: China Trade Talks, Walmart Earnings, and Take-Two on the GTA Hot Seat
Option Traders Moderately Bearish in Pfizer (PFE), With Shares Down $-0.07 (-0.33%) Near $22.46.